Efficacy News and Research

RSS

Effectiveness of mRNA BNT162b2 COVID-19 vaccine in immunocompromised individuals

Israeli researchers evaluate the antibody response in ICPs to assess antibody-mediated immunity following vaccination with the Pfizer-BioNTech vaccine.

26 Oct 2021

New computer-aided data tool could improve treatment for many diseases

Scientists from Queen's University Belfast have developed a computer-aided data tool that could improve treatment for a range of illnesses.

26 Oct 2021

Non-pharmaceutical interventions reduce likelihood of SARS-CoV-2 infection following high-risk exposure

Researchers have been investigating the efficacy of many of the non-pharmaceutical interventions applied and exploring the theory that mask use results in less severe symptoms in individuals infected with SARS-COV-2.

26 Oct 2021

Evaluation of COVID-19 infection risk during US spring semester in-person teaching

The main objective of the study was to determine the rates of in-person schooling and understand the school-based mitigation measures that were modified over the semester.

26 Oct 2021

Study: Understanding the reasons behind vaccine hesitancy is key to boosting global uptake of immunization

Exploring complex reasons behind hesitancy for new vaccinations and better education for healthcare professionals is key to boosting global uptake of immunization against diseases and viruses including Covid-19, a study shows.

26 Oct 2021

High and increasing SARS-CoV-2 infection prevalence amongst school-aged children in England

The latest round of the REACT-1 study indicates SARS-CoV-2 continues to spread among children.

26 Oct 2021

UQ-developed oral vaccine marks a leap forward in the battle against hookworm infections

There's been a significant breakthrough in the development of a vaccine to prevent hookworm infection – a parasite which causes serious disease in tens of millions of people globally.

26 Oct 2021

Researchers reveal mechanism which allows antibiotics like penicillin to kill MRSA

The mechanism which allows β-lactam antibiotics, including penicillin, to kill MRSA has been revealed for the first time.

25 Oct 2021

New data reveals safety, efficacy of nusinersen drug delivery method for SMA patients with advanced disease

A recently published paper details the safety and efficacy of nusinersen administration via a subcutaneous intrathecal catheter system (SIC) for SMA patients with advanced disease.

25 Oct 2021

Researchers develop ferritin-based nanomedicine for targeted delivery of leukemia therapy

Researchers from the Institute of Process Engineering\ of the Chinese Academy of Sciences, Peking University and Zhujiang Hospital of Southern Medical University have developed a ferritin (Fn)-based nanomedicine for targeted delivery of arsenic (As) and efficient therapy against diverse leukemia types.

25 Oct 2021

Study finds FDA-approved drug has potent antiviral activity against SARS-CoV-2 and variants of concern

A new study aimed to examine the antiviral potential of atovaquone against the original SARS-CoV-2 strain and other variants of concern.

25 Oct 2021

Cancer patients have impaired antibody responses to COVID-19 mRNA vaccines

A new study posted to the medRxiv* preprint server studies the neutralizing antibody response in cancer patients diagnosed with chronic lymphocytic leukemia (CLL), lung cancer, breast cancer, and various non-Hodgkin’s lymphomas (NHL), post-reception of two doses of messenger RNA (mRNA) vaccines.

25 Oct 2021

A comparison between Pfizer/BioNTech's and Sinopharm's SARS-CoV-2 vaccines

Researchers compare antibody titers elicited the Pfizer‐BioNTech mRNA and the classic inactivated virus Sinopharm vaccines.

24 Oct 2021

Does previous SARS-CoV-2 infection affect vaccine-induced immunity?

Researchers report the binding and pseudo-neutralizing antibody titers elicited after patients had received either the Pfizer-BioNTech or AstraZeneca vaccines.

24 Oct 2021

Vaccination data from Puerto Rico strongly supports COVID19 booster shots

In a recent study, researchers from the U.S. examined the vaccine effectiveness against SARS-CoV-2 infections in Puerto Rico.

24 Oct 2021

Researchers identify mechanism behind insufficient treatment efficacy of psoriasis drugs

Interleukin-12 - a messenger molecule of immune cells - was long considered to trigger the development of psoriasis.

22 Oct 2021

SARS-CoV-2 anti-nucleocapsid antibodies reduce risk of reinfection for at least eight months

A new study concludes that at least with predominantly wild-type variants, the risk of reinfection with the virus among unvaccinated people is reduced by 80% or more.

22 Oct 2021

Immunogenicity and efficacy of adjuvanted SARS-CoV-2 beta variant subunit booster in rhesus macaques

Scientists studied the efficacy of an intranasal booster composed of beta variant-spike protein S1 with IL-15 and TLR agonists in macaques that were previously immunized.

22 Oct 2021

Hydrogel-based vaccine delivery system evokes antibody response against SARS-CoV-2

Researchers from Stanford University have been attempting to create a hydrogel-based vaccine delivery system that could improve the immune response's strength and duration.

22 Oct 2021

SARS-CoV-2 cocktail with three antibodies potent in preclinical testing

Amidst growing concerns on the use and potential benefits of convalescent plasma therapy, a research group in the United States has identified three human antibodies (Abs) that, when combined, demonstrate both robust viral suppressive properties against all tested severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Variants of Concern (VoC) in vitro and profound antiviral efficacy in vivo.

22 Oct 2021

Efficacy News and Research

Effectiveness of mRNA BNT162b2 COVID-19 vaccine in immunocompromised individuals

New computer-aided data tool could improve treatment for many diseases

Non-pharmaceutical interventions reduce likelihood of SARS-CoV-2 infection following high-risk exposure

Evaluation of COVID-19 infection risk during US spring semester in-person teaching

Study: Understanding the reasons behind vaccine hesitancy is key to boosting global uptake of immunization

High and increasing SARS-CoV-2 infection prevalence amongst school-aged children in England

UQ-developed oral vaccine marks a leap forward in the battle against hookworm infections

Researchers reveal mechanism which allows antibiotics like penicillin to kill MRSA

New data reveals safety, efficacy of nusinersen drug delivery method for SMA patients with advanced disease

Researchers develop ferritin-based nanomedicine for targeted delivery of leukemia therapy

Study finds FDA-approved drug has potent antiviral activity against SARS-CoV-2 and variants of concern

Cancer patients have impaired antibody responses to COVID-19 mRNA vaccines

A comparison between Pfizer/BioNTech's and Sinopharm's SARS-CoV-2 vaccines

Does previous SARS-CoV-2 infection affect vaccine-induced immunity?

Vaccination data from Puerto Rico strongly supports COVID19 booster shots

Researchers identify mechanism behind insufficient treatment efficacy of psoriasis drugs

SARS-CoV-2 anti-nucleocapsid antibodies reduce risk of reinfection for at least eight months

Immunogenicity and efficacy of adjuvanted SARS-CoV-2 beta variant subunit booster in rhesus macaques

Hydrogel-based vaccine delivery system evokes antibody response against SARS-CoV-2

SARS-CoV-2 cocktail with three antibodies potent in preclinical testing

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News